相似文献
1
Circulating levels of prolactin in human breast cancer.
Br J Cancer. 1975 Aug;32(2):160-7. doi: 10.1038/bjc.1975.145.
2
3
Serum hormones in human breast cancer subjects.
Neoplasma. 1989;36(2):221-31.
4
Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
Br J Cancer. 1983 Feb;47(2):269-75. doi: 10.1038/bjc.1983.35.
5
Prolactin and breast cancer risk.
Med J Aust. 1990 Oct 15;153(8):469-73.
6
Plasma concentrations of C-19 steroids, estrogens, FSH, LH and prolactin in post-menopausal women with an without breast cancer.
Oncology. 1981;38(6):365-8. doi: 10.1159/000225589.
7
Subnormal 24-hour mean concentration and abnormal 24-hour profile of plasma LH in the luteal phase in women with breast cancer.
Anticancer Res. 1981;1(5):305-8.
8
Endogenous sex hormones, prolactin, and breast cancer in premenopausal women.
J Natl Cancer Inst. 1986 Sep;77(3):613-6. doi: 10.1093/jnci/77.3.613.
9
Gynaecomastia complicating the treatment of myeloma.
Br J Cancer. 1983 Jul;48(1):69-74. doi: 10.1038/bjc.1983.158.
10
Serum prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer.
Eur J Cancer (1965). 1977 Jul;13(7):677-84. doi: 10.1016/0014-2964(77)90053-6.
引用本文的文献
1
Serum Prolactin Levels as a Novel, Practical Marker for Predicting Malignant Diseases of the Breast.
Cureus. 2024 Apr 16;16(4):e58375. doi: 10.7759/cureus.58375. eCollection 2024 Apr.
2
Prolactin and breast cancer etiology: an epidemiologic perspective.
J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):41-53. doi: 10.1007/s10911-008-9063-y. Epub 2008 Feb 2.
3
The role of prolactin in mammary carcinoma.
Endocr Rev. 2003 Feb;24(1):1-27. doi: 10.1210/er.2001-0036.
4
Factors that promote the development of human breast cancer.
Environ Health Perspect. 1983 Apr;50:209-18. doi: 10.1289/ehp.8350209.
5
Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.
Br J Cancer. 1983 Feb;47(2):269-75. doi: 10.1038/bjc.1983.35.
6
Epidemiology and endocrinology of benign breast disease.
Breast Cancer Res Treat. 1985;6(1):5-36. doi: 10.1007/BF01806008.
7
Plasma lipids and prolactin in patients with breast cancer.
Br J Cancer. 1986 Sep;54(3):439-46. doi: 10.1038/bjc.1986.195.
8
Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer.
Br J Cancer. 1992 Mar;65(3):456-60. doi: 10.1038/bjc.1992.92.
本文引用的文献
1
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.
Biochem J. 1963 Oct;89(1):114-23. doi: 10.1042/bj0890114.
2
Adrenalectomy and hypophysectomy for advanced cancer of the breast.
Lancet. 1960 May 28;1(7135):1148-53. doi: 10.1016/s0140-6736(60)91039-4.
3
Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone.
Endocrinology. 1966 Jul;79(1):10-8. doi: 10.1210/endo-79-1-10.
4
Prolactin-dependent rat mammary cancer: a model for man?
Trans Assoc Am Physicians. 1969;82:225-38.
5
Elevated serum prolactin levels after pituitary-stalk section in man.
N Engl J Med. 1971 Sep 23;285(13):707-10. doi: 10.1056/NEJM197109232851302.
6
Circadian periodicity of serum prolactin concentration in man.
Br Med J. 1972 Sep 2;3(5826):561-2. doi: 10.1136/bmj.3.5826.561.
7
Inhibition of mammary tumorigenesis by ergot alkaloids and promotion of mammary tumorigenesis by pituitary isografts in adreno-ovariectomized mice.
J Natl Cancer Inst. 1972 Mar;48(3):715-9.
8
Human prolactin: 24-hour pattern with increased release during sleep.
Science. 1972 Sep 29;177(4055):1205-7. doi: 10.1126/science.177.4055.1205.
9
Prolactin and mammary gland carcinogenesis. The problem of human prolactin.
Int J Cancer. 1970 Mar 15;5(2):167-75. doi: 10.1002/ijc.2910050202.
10
Mammotropic effect of prolactin enhanced by thyroidectomy.
Nature. 1974 Apr 5;248(448):525-6. doi: 10.1038/248525a0.
Zotero 插件